bioAffinity
  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations
Select Page

bioAffinity Technologies CEO Maria Zannes Shares CyPath®Lung with The Empowered Patient Podcast

by Maria Zannes | Mar 6, 2023 | Articles, News

MARCH 6, 2023 The Empowered Patient podcast host Karen Jagoda recently interviewed bioAffinity Technologies President and CEO Maria Zannes about the development of the CyPath® Lung test for the detection of early-stage lung cancer. Hear the podcast at...

“Fireside Chat” with Maria Zannes, CEO of bioAffinity Technologies, Inc. (NASDAQ: BIAF)

by Maria Zannes | Feb 22, 2023 | Articles, News

FEBRUARY 22, 2023 bioAffinity Technologies President and CEO Maria Zannes recently joined host Seth Farbman on his podcast From Start-Up to Stock Exchange. Listen here https://lnkd.in/g-vkTfKv to learn more about the need for early screening for lung cancer when it is...

Meet BioAffinity Technologies: Fly exclusive interview with CEO Maria Zannes

by Dale Harrison | Dec 28, 2022 | Articles, News

Meet BioAffinity Technologies: Fly exclusive interview with CEO Maria Zannes DECEMBER 28, 2022 As published in the The Fly By: Jessica de Sa-Mota BioAffinity focuses on the development of noninvasive, early-stage cancer diagnosis and targeted cancer treatment In an...

SA Cancer Diagnostic Company Adding Research Talent

by Dale Harrison | Dec 23, 2022 | Articles, News

SA Cancer Diagnostic Company Adding Research Talent DECEMBER 23, 2022 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc. is making multiple personnel moves in an effort to...

Maria Zannes named to TEXAS 100 Influential professionals to watch in 2023

by Dale Harrison | Dec 21, 2022 | Articles, News

TEXAS 100 Influential professionals to watch in 2023 DECEMBER 21, 2022 As published in the San Antonio Business Journal By: Colin Pope – Editor, Austin Business Journal Our annual Texas 100 is a list of impactful Texans who will likely play crucial roles in the...

After going public, SA company charts next course

by Dale Harrison | Nov 29, 2022 | Articles, News

After going public, SA company charts next course NOVEMBER 29, 2022 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal Fresh off of filing its first earnings report as a publicly traded company, San...
« Older Entries

Categories

  • Articles (17)
  • Events (35)
  • News (42)
  • Press Releases (60)
  • Publications (15)

Recent Posts

  • bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results March 31, 2023
  • bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer March 28, 2023
  • bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023 March 23, 2023
  • bioAffinity Technologies CEO Maria Zannes Shares CyPath®Lung with The Empowered Patient Podcast March 6, 2023
  • bioAffinity CEO To Moderate Health Cell Panel on Resources for Start-Ups March 6, 2023

Learn About CyPath Lung

CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations
Copyright © 2023 bioAffinity Technologies, Inc.